Showing results 1 to 20 of 75
next >
Issue Date | Title | Author(s) |
2022 | Is there a place for a molecular diagnostic test for pelvic inflammatory disease in primary care? An exploratory qualitative study. | Bittleston, H; Hocking, JS; Goller, JL; Coombe, J; Bateson, D; Sweeney, S; Fleming, K; Huston, WM; Fuller, SS |
2022 | Repeat infections with chlamydia in women may be more transcriptionally active with lower responses from some immune genes. | Huston, WM; Lawrence, A; Wee, BA; Thomas, M; Timms, P; Vodstrcil, LA; McNulty, A; McIvor, R; Worthington, K; Donovan, B; Phillips, S; Chen, MY; Fairley, CK; Hocking, JS |
2021-12-31 | Design, synthesis and biological evaluation of P2-modified proline analogues targeting the HtrA serine protease in Chlamydia. | Hwang, J; Strange, N; Mazraani, R; Phillips, MJ; Gamble, AB; Huston, WM; Tyndall, JDA |
2021-11 | Optimization of peptide-based inhibitors targeting the HtrA serine protease in Chlamydia: Design, synthesis and biological evaluation of pyridone-based and N-Capping group-modified analogues. | Hwang, J; Strange, N; Phillips, MJA; Krause, AL; Heywood, A; Gamble, AB; Huston, WM; Tyndall, JDA |
2021-06-01 | Cervicovaginal microbiota and women's health outcomes | Bryant, CJ; Burke, C; Huston, WM |
2021-05-17 | Dual RNA-seq analysis of in vitro infection multiplicity and RNA depletion methods in Chlamydia-infected epithelial cells | Hayward, RJ; Humphrys, MS; Huston, WM; Myers, GSA |
2021-03-01 | Chlamydial clinical isolates show subtle differences in persistence phenotypes and growth in vitro | Thomas, M; Lawrence, A; Kroon, S; Vodstrcil, LA; Phillips, S; Hocking, JS; Timms, P; Huston, WM |
2021-01 | Koala cathelicidin PhciCath5 has antimicrobial activity, including against Chlamydia pecorum. | Peel, E; Cheng, Y; Djordjevic, JT; O'Meally, D; Thomas, M; Kuhn, M; Sorrell, TC; Huston, WM; Belov, K |
2020-09-09 | A retrospective cohort study examining STI testing and perinatal records demonstrates reproductive health burden of chlamydia and gonorrhea. | Callan, T; Debattista, J; Berry, B; Brown, J; Woodcock, S; Hocking, JS; Huston, WM |
2020-01-01 | Structure and Metal Binding Properties of Chlamydia trachomatis YtgA | Luo, Z; Neville, SL; Campbell, R; Morey, JR; Menon, S; Thomas, M; Eijkelkamp, BA; Ween, MP; Huston, WM; Kobe, B; McDevittd, CA |
2020-01 | Editorial: Interplay of Infection and Microbiome. | Huston, WM; Tachedjian, G |
2019-11-19 | Early Transcriptional Landscapes of Chlamydia trachomatis-Infected Epithelial Cells at Single Cell Resolution | Hayward, RJ; Marsh, JW; Humphrys, MS; Huston, WM; Myers, GSA |
2019-09-15 | Structure-activity analysis of peptidic Chlamydia HtrA inhibitors | Agbowuro, AA; Hwang, J; Peel, E; Mazraani, R; Springwald, A; Marsh, JW; McCaughey, L; Gamble, AB; Huston, WM; Tyndall, JDA |
2019-08-05 | Early transcriptional landscapes of Chlamydia trachomatis-infected epithelial cells at single cell resolution | Hayward, RJ; Marsh, JW; Humphrys, MS; Huston, WM; Myers, GSA |
2019-06-24 | Chromatin accessibility dynamics of Chlamydia-infected epithelial cells | Hayward, RJ; Marsh, JW; Humphrys, MS; Huston, WM; Myers, GSA |
2019-04-01 | Evaluation of a PGP3 ELISA for surveillance of the burden of Chlamydia infection in women from Australia and Samoa | Mazraani, R; Timms, P; Hill, PC; Suaalii-Sauni, T; Niupulusu, T; Temese, SVA; Iosefa-Siitia, L; Auvaa, L; Tapelu, SA; Motu, MF; Righarts, A; Walsh, MS; Rombauts, L; Allan, JA; Horner, P; Huston, WM |
2019-03-07 | Fresh faces and new approaches at Pathogens and Disease | Huston, WM; Coers, J; Garzino-Demo, A |
2019-03-04 | High expression of IDO1 and TGF-?1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-? response | Ziklo, N; Huston, WM; Taing, K; Timms, P |
2019-03-01 | A sponsorship action plan for increasing diversity in STEMM | Huston, WM; Cranfield, CG; Forbes, SL; Leigh, A |
2019-01-02 | Life inside and out: making and breaking protein disulfide bonds in Chlamydia | Christensen, S; McMahon, RM; Martin, JL; Huston, WM |